Senores Pharmaceuticals Quarterly Results for Trading Insights
SENORES • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹30 Cr
QSept 2025
Senores Pharmaceuticals Quarterly Results Key Highlights
- Revenue of ₹159 Cr in Sept 2025 (+35.9% vs Mar 2025, +59.0% vs Sept 2024)
- Net Profit of ₹30 Cr in Sept 2025 (+66.7% vs Mar 2025, +130.8% vs Sept 2024)
- EBITDA of ₹47 Cr in Sept 2025 (+113.6% vs Mar 2025)
- Operating Margin of 27.0% in Sept 2025 (+17.0pp vs Mar 2025)
- Earnings Per Share of ₹6.54 in Sept 2025 (+71.7% vs Mar 2025)
Senores Pharmaceuticals Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 159 | 117 | 134 | 100 | 104 | 35.9% | 59.0% |
| Net Profit (₹ Cr) | 30 | 18 | 21 | 13 | 14 | - | - |
| EBITDA (₹ Cr) | 47 | 22 | 30 | 23 | 24 | - | - |
| EPS (₹) | 6.54 | 3.81 | 4.60 | 3.92 | 8.03 | - | - |
| Operating Margin (%) | 27.0% | 10.0% | 20.0% | 21.0% | 22.0% | - | - |
Senores Pharmaceuticals Share Price Trend Around Quarterly Results
Visualize Senores Pharmaceuticals's 1-year price movement across quarterly results — ideal for logging trades in Senores Pharmaceuticals share price
chart using Tickjournal. All values in ₹.
Related Pages for Senores Pharmaceuticals
Additional stock information and data for SENORES
Revenue Trend (₹ Cr)
Sept 2024
100
Jun 2025
134
Mar 2025
117
Sept 2025
159
Net Profit Trend (₹ Cr)
Sept 2024
13
Jun 2025
21
Mar 2025
18
Sept 2025
30
Operating Margin Trend (%)
Sept 2024
21.0%
Jun 2025
20.0%
Mar 2025
10.0%
Sept 2025
27.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Senores Pharmaceuticals quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1729.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 133.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6616.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3963.4 | 3,219 | 591 | +11.3% | - | 18.4% | 226.0 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1465.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1210.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores